Apolipoprotein E and clusterin inhibit the early phase of amyloid-β aggregation in an in vitro model of cerebral amyloid angiopathy

MLA

Yoshinori Endo, et al. “Apolipoprotein E and Clusterin Inhibit the Early Phase of Amyloid-β Aggregation in an in Vitro Model of Cerebral Amyloid Angiopathy.” Acta Neuropathologica Communications, vol. 7, no. 1, Jan. 2019, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s40478-019-0662-1.

APA

Yoshinori Endo, Kazuhiro Hasegawa, Ryo Nomura, Hidetaka Arishima, Ken-ichiro Kikuta, Taro Yamashita, Yasuteru Inoue, Mitsuharu Ueda, Yukio Ando, Mark R. Wilson, Tadanori Hamano, Yasunari Nakamoto, & Hironobu Naiki. (2019). Apolipoprotein E and clusterin inhibit the early phase of amyloid-β aggregation in an in vitro model of cerebral amyloid angiopathy. Acta Neuropathologica Communications, 7(1), 1–11. https://doi.org/10.1186/s40478-019-0662-1

Chicago

Yoshinori Endo, Kazuhiro Hasegawa, Ryo Nomura, Hidetaka Arishima, Ken-ichiro Kikuta, Taro Yamashita, Yasuteru Inoue, et al. 2019. “Apolipoprotein E and Clusterin Inhibit the Early Phase of Amyloid-β Aggregation in an in Vitro Model of Cerebral Amyloid Angiopathy.” Acta Neuropathologica Communications 7 (1): 1–11. doi:10.1186/s40478-019-0662-1.